Moossdorff-Steinhauser, Heidi F. A. http://orcid.org/0000-0002-9651-1731
Bols, Esther M. J.
Spaanderman, Marc E. A.
Dirksen, Carmen D.
Weemhoff, Mirjam
Nieman, Fred H. M.
Berghmans, Bary
Funding for this research was provided by:
ZonMw (80-84300-98-72001)
Article History
Received: 17 December 2018
Accepted: 25 March 2019
First Online: 25 April 2019
Ethics approval and consent to participate
: The studies MOTHERFIT1 and MOTHERFIT2 are registered as one trial in the Netherlands National Trial Register (NTR5971). The Medical Ethics Committee (METC) of the MUMC+ (central level) has approved MOTHERFIT1 at 21 December (METC162038) and MOTHERFIT2 at 22 December 2016 (METC162051). The remaining four participating hospitals (local level) received approval from their Medical Ethics Committees. Informed consent will be obtained from all study participants. This study has been designed in accordance with the Helsinki Accords and Dutch Medical Research Involving Human Subjects Act (WMO).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.